Autoimmune diseases associated with myasthenia gravis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The association of myasthenia gravis with other autoimmune diseases is well known. The characterization of autoimmune diseases clusters occurring in myasthenic patients in excess to that expected by chance may provide insights into shared pathophysiologic mechanisms. Recent studies suggest that the pathogenic heterogeneity of myasthenia gravis seems to influence both the rate and the characteristics of concurrent autoimmune diseases. The chronic nature of associated autoimmune diseases places a significant challenge in the care of patients with myasthenia gravis. Diagnosis of these disorders is complex, and depends on recognition of specific clinical features followed by appropriate autoantibody testing. Once the diagnosis of an associated autoimmune disease is reached, a multidisciplinary approach is usually needed to optimize the therapeutic strategies, avoiding at the same time the side effects that can potentially derive from the combination of multiple immunosuppressive agents.

Original languageEnglish
Title of host publicationNovel Challenges in Myasthenia Gravis
PublisherNova Science Publishers, Inc.
Pages133-151
Number of pages19
ISBN (Print)9781634830003, 9781634829779
Publication statusPublished - Jul 1 2015

Fingerprint

Myasthenia Gravis
Autoimmune Diseases
Muscle Weakness
Immunosuppressive Agents
Autoantibodies
Patient Care

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Iorio, R. (2015). Autoimmune diseases associated with myasthenia gravis. In Novel Challenges in Myasthenia Gravis (pp. 133-151). Nova Science Publishers, Inc..

Autoimmune diseases associated with myasthenia gravis. / Iorio, Raffaele.

Novel Challenges in Myasthenia Gravis. Nova Science Publishers, Inc., 2015. p. 133-151.

Research output: Chapter in Book/Report/Conference proceedingChapter

Iorio, R 2015, Autoimmune diseases associated with myasthenia gravis. in Novel Challenges in Myasthenia Gravis. Nova Science Publishers, Inc., pp. 133-151.
Iorio R. Autoimmune diseases associated with myasthenia gravis. In Novel Challenges in Myasthenia Gravis. Nova Science Publishers, Inc. 2015. p. 133-151
Iorio, Raffaele. / Autoimmune diseases associated with myasthenia gravis. Novel Challenges in Myasthenia Gravis. Nova Science Publishers, Inc., 2015. pp. 133-151
@inbook{328cbbae693b494db6ad08a1d4811ecf,
title = "Autoimmune diseases associated with myasthenia gravis",
abstract = "The association of myasthenia gravis with other autoimmune diseases is well known. The characterization of autoimmune diseases clusters occurring in myasthenic patients in excess to that expected by chance may provide insights into shared pathophysiologic mechanisms. Recent studies suggest that the pathogenic heterogeneity of myasthenia gravis seems to influence both the rate and the characteristics of concurrent autoimmune diseases. The chronic nature of associated autoimmune diseases places a significant challenge in the care of patients with myasthenia gravis. Diagnosis of these disorders is complex, and depends on recognition of specific clinical features followed by appropriate autoantibody testing. Once the diagnosis of an associated autoimmune disease is reached, a multidisciplinary approach is usually needed to optimize the therapeutic strategies, avoiding at the same time the side effects that can potentially derive from the combination of multiple immunosuppressive agents.",
author = "Raffaele Iorio",
year = "2015",
month = "7",
day = "1",
language = "English",
isbn = "9781634830003",
pages = "133--151",
booktitle = "Novel Challenges in Myasthenia Gravis",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Autoimmune diseases associated with myasthenia gravis

AU - Iorio, Raffaele

PY - 2015/7/1

Y1 - 2015/7/1

N2 - The association of myasthenia gravis with other autoimmune diseases is well known. The characterization of autoimmune diseases clusters occurring in myasthenic patients in excess to that expected by chance may provide insights into shared pathophysiologic mechanisms. Recent studies suggest that the pathogenic heterogeneity of myasthenia gravis seems to influence both the rate and the characteristics of concurrent autoimmune diseases. The chronic nature of associated autoimmune diseases places a significant challenge in the care of patients with myasthenia gravis. Diagnosis of these disorders is complex, and depends on recognition of specific clinical features followed by appropriate autoantibody testing. Once the diagnosis of an associated autoimmune disease is reached, a multidisciplinary approach is usually needed to optimize the therapeutic strategies, avoiding at the same time the side effects that can potentially derive from the combination of multiple immunosuppressive agents.

AB - The association of myasthenia gravis with other autoimmune diseases is well known. The characterization of autoimmune diseases clusters occurring in myasthenic patients in excess to that expected by chance may provide insights into shared pathophysiologic mechanisms. Recent studies suggest that the pathogenic heterogeneity of myasthenia gravis seems to influence both the rate and the characteristics of concurrent autoimmune diseases. The chronic nature of associated autoimmune diseases places a significant challenge in the care of patients with myasthenia gravis. Diagnosis of these disorders is complex, and depends on recognition of specific clinical features followed by appropriate autoantibody testing. Once the diagnosis of an associated autoimmune disease is reached, a multidisciplinary approach is usually needed to optimize the therapeutic strategies, avoiding at the same time the side effects that can potentially derive from the combination of multiple immunosuppressive agents.

UR - http://www.scopus.com/inward/record.url?scp=84957025894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957025894&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84957025894

SN - 9781634830003

SN - 9781634829779

SP - 133

EP - 151

BT - Novel Challenges in Myasthenia Gravis

PB - Nova Science Publishers, Inc.

ER -